Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Giorgi

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Farmaco (Societa Chimica Italiana : 1989)|March 1, 1992
Structure-activity studies on a 1,2,3-triazole derivative, a potent in vitro inhibitor of prostaglandin synthesis: the role of the heterocyclic ringG Biagi, G Dell'Omodarme, M Ferretti, et al.
Bollettino Chimico Farmaceutico|December 22, 1998
New 1,2,3-triazole derivatives (ureas, amides, urethanes) with a potential biological interestG Biagi, I Giorgi, O Livi, et al.
Journal of Pharmaceutical Sciences|September 1, 1993
Studies on specific inhibition of benzodiazepine receptor binding by some C-benzoyl-1,2,3-triazole derivativesG Biagi, I Giorgi, O Livi, et al.
Farmaco (Societa Chimica Italiana : 1989)|March 1, 1993
Xanthine oxidase (XO): relative configuration of complexes formed by the enzyme, 2- or 8-n-alkyl-hypoxanthines and 2-n-alkyl-8-azahypoxanthines. XIIG Biagi, I Giorgi, O Livi, et al.
Farmaco (Societa Chimica Italiana : 1989)|April 1, 1995
Xanthine oxidase (XO). 4(5)-aminosubstituted-5(4)-carboxyamido-1H-1,2, 3-triazoles: a new class of monocyclic triazole inhibitorsG Biagi, I Giorgi, O Livi, et al.
Farmaco (Societa Chimica Italiana : 1989)|August 1, 1993
1,2,3-Triazole[4,5-d]pyridazines--I. Analogues of prostaglandin synthesis inhibitorsG Biagi, M Ferretti, I Giorgi, et al.
Farmaco (Societa Chimica Italiana : 1989)|December 1, 1996
New chiral inhibitors of induced platelet aggregation: the enantiomeric specificity of (R)- and (S)-methyl and ethyl esters of 1-(4-[(1-hydroxycarbonyl)-ethoxy]-benzyl)-1H-1,2,3-triazole as a tool for determining their biological targetG Biagi, I Giorgi, O Livi, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|April 20, 2000
[Work and alcohol: considerations on a caseload of patients undergoing treatment]G Biscaldi, G Vittadini, I Giorgi, et al.
Farmaco (Societa Chimica Italiana : 1989)|January 1, 1992
An 1,2,3-triazole derivative bioisoster of a potent in vitro prostaglandin synthesis inhibitor: preparation and biological activityG Biagi, G Dell'Omodarme, I Giorgi, et al.
Studies in Health Technology and Informatics|December 8, 1996
Spreading the clinical information system: which users are satisfied?M C Mazzoleni, P Baiardi, I Giorgi, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Farmaco (Societa Chimica Italiana : 1989)|March 1, 1992
Structure-activity studies on a 1,2,3-triazole derivative, a potent in vitro inhibitor of prostaglandin synthesis: the role of the heterocyclic ringG Biagi, G Dell'Omodarme, M Ferretti, et al.
Bollettino Chimico Farmaceutico|December 22, 1998
New 1,2,3-triazole derivatives (ureas, amides, urethanes) with a potential biological interestG Biagi, I Giorgi, O Livi, et al.
Journal of Pharmaceutical Sciences|September 1, 1993
Studies on specific inhibition of benzodiazepine receptor binding by some C-benzoyl-1,2,3-triazole derivativesG Biagi, I Giorgi, O Livi, et al.
Farmaco (Societa Chimica Italiana : 1989)|March 1, 1993
Xanthine oxidase (XO): relative configuration of complexes formed by the enzyme, 2- or 8-n-alkyl-hypoxanthines and 2-n-alkyl-8-azahypoxanthines. XIIG Biagi, I Giorgi, O Livi, et al.
Farmaco (Societa Chimica Italiana : 1989)|April 1, 1995
Xanthine oxidase (XO). 4(5)-aminosubstituted-5(4)-carboxyamido-1H-1,2, 3-triazoles: a new class of monocyclic triazole inhibitorsG Biagi, I Giorgi, O Livi, et al.
Farmaco (Societa Chimica Italiana : 1989)|August 1, 1993
1,2,3-Triazole[4,5-d]pyridazines--I. Analogues of prostaglandin synthesis inhibitorsG Biagi, M Ferretti, I Giorgi, et al.
Farmaco (Societa Chimica Italiana : 1989)|December 1, 1996
New chiral inhibitors of induced platelet aggregation: the enantiomeric specificity of (R)- and (S)-methyl and ethyl esters of 1-(4-[(1-hydroxycarbonyl)-ethoxy]-benzyl)-1H-1,2,3-triazole as a tool for determining their biological targetG Biagi, I Giorgi, O Livi, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|April 20, 2000
[Work and alcohol: considerations on a caseload of patients undergoing treatment]G Biscaldi, G Vittadini, I Giorgi, et al.
Farmaco (Societa Chimica Italiana : 1989)|January 1, 1992
An 1,2,3-triazole derivative bioisoster of a potent in vitro prostaglandin synthesis inhibitor: preparation and biological activityG Biagi, G Dell'Omodarme, I Giorgi, et al.
Studies in Health Technology and Informatics|December 8, 1996
Spreading the clinical information system: which users are satisfied?M C Mazzoleni, P Baiardi, I Giorgi, et al.
Pageof 9